Interestingly, ARHGAP15, which is a Rac-specific negative regulator, is also heavily involved in actin cytoskeleton dynamics [47], suggesting that its interaction with EFR3B affects WM health in AD patients through regulating myelination in axons. Here, EFR3B is linked to Alzheimer disease.